Pacific Edge Limited (PEB.AX)
AUD 0.14
(0.0%)
AUD 0.14
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 71.34 Million NZD | -26.53% |
| 2023 | 97.11 Million NZD | -21.69% |
| 2022 | 124.02 Million NZD | 297.72% |
| 2021 | 31.18 Million NZD | 61.34% |
| 2020 | 19.32 Million NZD | 16.67% |
| 2019 | 16.56 Million NZD | -15.76% |
| 2018 | 19.66 Million NZD | -16.54% |
| 2017 | 23.56 Million NZD | -27.12% |
| 2016 | 32.33 Million NZD | 155.92% |
| 2015 | 12.63 Million NZD | -44.42% |
| 2014 | 22.73 Million NZD | 85.97% |
| 2013 | 12.22 Million NZD | -34.45% |
| 2012 | 18.64 Million NZD | 465.91% |
| 2011 | 3.29 Million NZD | 82.95% |
| 2010 | 1.8 Million NZD | 100.87% |
| 2009 | 896.61 Thousand NZD | -71.79% |
| 2008 | 3.17 Million NZD | 464.59% |
| 2007 | 562.96 Thousand NZD | -56.52% |
| 2006 | 1.29 Million NZD | -6.38% |
| 2005 | 1.38 Million NZD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 76.25 Million NZD | 0.0% |
| 2024 Q3 | 65.44 Million NZD | -14.17% |
| 2024 Q4 | 71.34 Million NZD | 9.02% |
| 2024 Q1 | 76.25 Million NZD | -16.12% |
| 2024 FY | 71.34 Million NZD | -26.53% |
| 2023 Q2 | 106.75 Million NZD | 0.0% |
| 2023 Q4 | 90.91 Million NZD | 0.0% |
| 2023 FY | 97.11 Million NZD | -21.69% |
| 2023 Q3 | 90.91 Million NZD | -14.84% |
| 2023 Q1 | 106.75 Million NZD | -7.39% |
| 2022 Q3 | 115.28 Million NZD | 15.32% |
| 2022 Q4 | 115.28 Million NZD | 0.0% |
| 2022 FY | 124.02 Million NZD | 297.72% |
| 2022 Q1 | 99.97 Million NZD | 220.58% |
| 2022 Q2 | 99.97 Million NZD | 0.0% |
| 2021 FY | 31.18 Million NZD | 61.34% |
| 2021 Q2 | 36.98 Million NZD | 0.0% |
| 2021 Q1 | 36.98 Million NZD | 91.34% |
| 2021 Q4 | 31.18 Million NZD | 0.0% |
| 2021 Q3 | 31.18 Million NZD | -15.68% |
| 2020 Q1 | 9.8 Million NZD | -40.79% |
| 2020 Q4 | 19.32 Million NZD | 0.0% |
| 2020 Q2 | 9.8 Million NZD | 0.0% |
| 2020 Q3 | 19.32 Million NZD | 97.04% |
| 2020 FY | 19.32 Million NZD | 16.67% |
| 2019 Q1 | 13.8 Million NZD | -29.81% |
| 2019 FY | 16.56 Million NZD | -15.76% |
| 2019 Q4 | 16.56 Million NZD | 0.0% |
| 2019 Q3 | 16.56 Million NZD | 20.02% |
| 2019 Q2 | 13.8 Million NZD | 0.0% |
| 2018 Q1 | 14.97 Million NZD | -36.46% |
| 2018 FY | 19.66 Million NZD | -16.54% |
| 2018 Q4 | 19.66 Million NZD | 0.0% |
| 2018 Q3 | 19.66 Million NZD | 31.35% |
| 2018 Q2 | 14.97 Million NZD | 0.0% |
| 2017 Q1 | 23.41 Million NZD | -27.58% |
| 2017 FY | 23.56 Million NZD | -27.12% |
| 2017 Q4 | 23.56 Million NZD | 33.07% |
| 2017 Q3 | 17.7 Million NZD | -24.37% |
| 2017 Q2 | 23.41 Million NZD | 0.0% |
| 2016 Q3 | 32.33 Million NZD | -18.23% |
| 2016 Q4 | 32.33 Million NZD | 0.0% |
| 2016 FY | 32.33 Million NZD | 155.92% |
| 2016 Q1 | 39.53 Million NZD | 212.97% |
| 2016 Q2 | 39.53 Million NZD | 0.0% |
| 2015 FY | 12.63 Million NZD | -44.42% |
| 2015 Q1 | 18.19 Million NZD | -19.96% |
| 2015 Q4 | 12.63 Million NZD | 0.0% |
| 2015 Q3 | 12.63 Million NZD | -30.56% |
| 2015 Q2 | 18.19 Million NZD | 0.0% |
| 2014 Q2 | 8.08 Million NZD | 0.0% |
| 2014 FY | 22.73 Million NZD | 85.97% |
| 2014 Q4 | 22.73 Million NZD | 0.0% |
| 2014 Q3 | 22.73 Million NZD | 181.05% |
| 2014 Q1 | 8.08 Million NZD | -33.83% |
| 2013 Q3 | 12.22 Million NZD | 0.0% |
| 2013 FY | 12.22 Million NZD | -34.45% |
| 2013 Q4 | 12.22 Million NZD | 0.0% |
| 2012 Q4 | 18.64 Million NZD | 0.0% |
| 2012 FY | 18.64 Million NZD | 465.91% |
| 2011 FY | 3.29 Million NZD | 82.95% |
| 2011 Q4 | 3.29 Million NZD | 0.0% |
| 2010 FY | 1.8 Million NZD | 100.87% |
| 2010 Q4 | 1.8 Million NZD | 0.0% |
| 2009 Q4 | 896.61 Thousand NZD | 0.0% |
| 2009 FY | 896.61 Thousand NZD | -71.79% |
| 2008 FY | 3.17 Million NZD | 464.59% |
| 2008 Q4 | 3.17 Million NZD | 0.0% |
| 2007 FY | 562.96 Thousand NZD | -56.52% |
| 2006 FY | 1.29 Million NZD | -6.38% |
| 2005 FY | 1.38 Million NZD | 0.0% |
| 2005 Q4 | 1.38 Million NZD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Australian Clinical Labs Limited | 593.06 Million AUD | 87.969% |
| BCAL Diagnostics Limited | 12.26 Million AUD | -481.696% |
| Genetic Signatures Limited | 67.28 Million AUD | -6.036% |
| Genetic Technologies Limited | 6.18 Million AUD | -1053.29% |
| Healius Limited | 2.98 Billion AUD | 97.608% |
| Imagion Biosystems Limited | 4.58 Million AUD | -1455.698% |
| Integral Diagnostics Limited | 744.27 Million AUD | 90.414% |
| INOVIQ Ltd | 21.7 Million AUD | -228.709% |
| Microba Life Sciences Limited | 58.04 Million AUD | -22.929% |
| Monash IVF Group Limited | 508.47 Million AUD | 85.968% |
| Rhythm Biosciences Limited | 1.51 Million AUD | -4597.975% |
| Sonic Healthcare Limited | 14.82 Billion AUD | 99.519% |